As the ICH E6(R2) addendum becomes a priority for sponsors, some initial best practices have become apparent through early innovators and adopters of the guidance. One of the most significant of these is the use of role-based dashboards to help visualize clinical trial status and performance. With dashboards, stakeholders can quickly see what’s going on and deliver all-important oversight more effectively.
This webinar presents a case study of a mid-sized pharmaceutical company that adopted four role-based dashboards to address its oversight objectives:
- Executive view of portfolio status
- VP ClinOps view of performance across studies and CROs
- Study manager view of site ranking and CRA performance
- CRA view of specific site performance
You’ll learn what motivated the sponsor to embrace these dashboards and how the dashboards have been working.
